Ginkgo Bioworks Holdings, Inc. (DNA)
DNANYSEBiotechnology: Biological Products (No Diagnostic Substances)
$12.15
-0.2200 (-1.78%) today
At the close, Nov 10, 4:00 PM ET. After hours $12.15 +1.17%
- Market cap
- $772.73m
- P/E
- –
- EPS, last 4 quarters
- $-4.20
- Dividend yield
- –
- Day range
- $11.63 to $12.73
- 52-week range
- $5.37 to $18.22
- Average volume
- –
- Previous close
- $12.37
Analysts
3 coveringUnderperform0 buy, 1 hold, 2 sell
Targets a year out average $8.00, -34.2% from here
Earnings
Next report
Dec 2025
+21.1%
Mar 2026
–
Jun 2026
–
Sep 2026
-10.3%
estimate reported, and the surprise
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | $59.40m | $33.40m | $19.47m | $20.16m |
| Gross profit | $29.19m | $26.09m | $16.38m | $18.44m |
| Operating income | -$105.39m | -$70.75m | -$71.37m | -$58.55m |
| Net income | -$80.75m | -$80.75m | -$82.59m | -$46.71m |
Last four quarters: revenue $132.42m, margin -219.6%, free cash flow –
News
8 latest- Ginkgo Bioworks: 3 Key Takeaways for Long-Term InvestorsThe Motley Fool · 3 days ago
- Ginkgo Bioworks Q3 Earnings Call HighlightsMarketBeat · 4 days ago
- Ginkgo Bioworks (DNA) Q3 2026 Earnings Call TranscriptThe Motley Fool · 5 days ago
- Ginkgo Bioworks Holdings, Inc. Q3 Loss Drops RTTNews · 5 days ago
- Ginkgo Bioworks Holdings, Inc. (DNA) Suffers a Larger Drop Than the General Market: Key InsightsZacks · Oct 29, 2026
- Cathie Wood Is Buying Archer Aviation Stock. Here's What History Says About Following Ark Into a Stock Down 62%.The Motley Fool · Oct 29, 2026
- Ginkgo Bioworks Holdings Consensus Price Target Raised 14.29% to $8.16Fintel · Oct 23, 2026
- Ginkgo Bioworks Holdings, Inc. (DNA) Stock Falls Amid Market Uptick: What Investors Need to KnowZacks · Oct 20, 2026
The company
Ginkgo Bioworks builds the tools that make biology easier to engineer for everyone. The company offers autonomous laboratories that replace manual laboratory work with robotics in the lab, greatly improving the productivity of scientists. Ginkgo's in-house autonomous lab is also available as a ' Cloud Lab ' through our Datapoints and Solutions contract research services. For more information, visit ginkgobioworks.com , read our blog, or follow us on social media channels such as X (@Ginkgo), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks), or LinkedIn.
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Exchange
- NYSE
- Region
- North America
- Website
- ginkgobioworks.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.